⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

February 1, 2026Anales de Pediatría (English Edition)Open Access

Adverse events after COVID-19 vaccination in the pediatric population in Spain

M. Ángeles Rivas Paterna Carla Pérez Ingidua Ana B. Rivas Paterna David Ortega Martínez Esther Aleo Luján Emilio Vargas Castrillón

View Full Paper

Ask AI

Bookmark

Share

Key Points

To assess the frequency and nature of adverse drug reactions (ADRs) following COVID-19 vaccination in children.
Survey of pediatric population in Spain.
Collection of data on reported adverse drug reactions.
Assessment of ADR severity and classification.
35.6% of participants reported at least one ADR, totaling 1437 reactions.
99.5% of reactions were mild and resolved spontaneously.
Injection site pain was the most common ADR at 57.1%.

Implication

Reports the safety profile of COVID-19 vaccination, revealing mild adverse reactions in children, suggesting overall acceptability.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Paterna et al. (2026) studied this question.

synapsesocial.com/papers/698c1c53267fb587c655eb17 https://doi.org/10.1016/j.anpede.2026.504088

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Serious Adverse Drug Reactions to COVID-19 Vaccines in the Pediatric Population: A Retrospective, Cross-Sectional Study Utilizing the Eudravigilance Database for the European Economic Area2025 · 1 citations
2Risk Factors Associated with Adverse Events Following COVID-19 Vaccination in Children Aged 5–11 Years: A Real-World Observational StudyCohort Study · 2026
3Influence of epidemiological and clinical factors in the reactogenicity to Comirnaty® vaccine in health care workers of a Spanish university teaching hospital (COVIVAC study)cohort · 2023 · 2 citations
4Individuals with a history of allergic disease experience immunogenic side effects of vaccination more frequentlyOriginal Research · 2026
5Short-term safety of COVID-19 vaccines in the underage population of Buenos Aires2025